Integrating Quantum Computing and Medicinal Chemistry to Accelerate hCNT Inhibitor Discovery (GRA-036)

Integrating Quantum Computing and Medicinal Chemistry to Accelerate hCNT Inhibitor Discovery is a documented award listed in the DePaul Resource Map (starting 2026). Funder: DePaul ↔ RFUMS partnership.

Summary ~

• Sponsor / funder: DePaul ↔ RFUMS partnership
• Program: AI in Biomedical Discovery and Healthcare
• Status: awarded
• Period: 2026 – —
• Lead unit: Jarvis CDM
• Amount: $67,000

Access (availability): 🟢 Green — open or routine · 🟡 Yellow — appointment or affiliation · 🔴 Red — restricted · ⚪/⚫ White/Black — not yet classified

Verification: ✓ confirmed · ~ likely · ? needs review · ✕ archived

Award details

• Topics: medicinal chemistry, quantum computing
• Award type: research grant

People

• Jindi Wu (PI)
• John K. Buolamwini (Collaborator)

Related resources

• CSC 397 — TOPICS IN COMPUTER SCIENCE — Introduction to Quantum Computing and Programming (topical_curriculum)
• Rosalind Franklin University of Medicine and Science (partnership_program)

Related outputs

No related outputs documented yet.

Related publications

No related publications documented yet.

Verification

• Status: ~ Likely current
• Notes: 2026 RFUMS collaborative award; parent program GRA-029. No DePaul facility named in source.

Sources

• DePaul–Rosalind Franklin awarded projects summary, 2026

Notes

Award metadata compiled from published DePaul research reporting. Listing here records documented activity; it is not an evaluation of the award, the people, or the unit.